ClinicalTrials.gg
RecruitingNCT03764748WMTUpdated Aug 19, 2024

Washed Microbiota Transplantation for Tourette's Syndrome

A Phase 1 interventional study of Washed Microbiota Transplantation in Tourette Syndrome, sponsored by The Second Hospital of Nanjing Medical University. Recruiting at 2 sites in China. Open to participants aged 6 Years to 17 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-08-19.

Sponsored by The Second Hospital of Nanjing Medical University · Phase 1, Interventional, and Treatment

How we know

From the registry’s dates

  • Started Apr 2024; still recruiting 2 years 7 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Phase 1
Study type
Interventional
Enrollment
30
Allocation
Not applicable
Ages
6 Years to 17 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 11 studies in Tourette Syndrome with a site in China — 6 open to participants now, 6 under way, none of them phase 3. Tourette Syndrome · China.

Planned enrollment
8th of 10
30 · median 60
Started
2024
with 2 others
Phase 1
Only one
of the 11
Registered
4th of 11
by date
Lead sponsor
1 of 11
The Second Hospital of Nanjing Medical University

Among the 11 studies in Tourette Syndrome with a site in China, this one is the 8th largest by planned enrollment of the 10 interventional ones that give a count, is one of 3 that started in 2024, is the only one in phase 1, and was the 4th registered.

Tourette Syndrome

240 studies on the registry are indexed under Tourette Syndrome; 40 are open to participants now.

Browse Tourette Syndrome studies →

Open to participants now

6 of the 11 studies in Tourette Syndrome with a site in China are open now. Recruiting first, the newest first:

All 6 open studies →

A study can be open while its sites in China have not opened yet or have stopped. Only those recruiting at a site in China →

Who these studies take

Of the 33 Tourette Syndrome studies recruiting now, 9 (27%) set no upper age limit and 22 (67%) stop at 75 or younger; 20 take children under 18; 9 take healthy volunteers.

This study: 6 Years to 17 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 11 studies in Tourette Syndrome with a site in China, or all of them as a file.
02

Study summary

This study aimed to evaluate the efficacy of washed microbiota transplantation in the treatment of Tourette's syndrome (TS).

Read the detailed description

Emerging scientific data support the significant role of microbiota in the modulation of the central nervous system. The reconstitution of gut microbiota might be a potential option to treat Tourette's syndrome (TS). FMT has been reported to be a highly effective therapy to restore the gut microbiota dysbiosis by transferring gut microbiota from healthy donors to patients. The newly improved methodology of FMT based on the automatic washing process and the related delivering consideration was named as washed microbiota transplantation (WMT) by the FMT-standardization study group. FMT has shown treatment potential in several gut-brain axis-related disorders, such as amyotrophic lateral sclerosis and Parkinson's disease, promoting us to investigate its treatment potential for Tourette's syndrome. In this study, investigators aimed to evaluate the efficacy of WMT for Tourette's syndrome and its comorbidities using specialized questionnaires for Tourette's syndrome and investigate the underlying mechanism.

03

Conditions studied

  • Tourette Syndrome

Keywords

  • Tic Disorders
  • Gut microbiota
  • Brain-gut axis
  • Washed Microbiota Transplantation
  • Tourette syndrome
04

Who can participate

Ages eligible
6 Years to 17 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Patients were aged 6 to 17 years (inclusive);
  2. Met the , Fifth Edition criteria for TS;
  3. Had a Yale Global Tic Severity Scale-Total Tic Score (YGTSS-TTS) of at least 20 at screening and baseline.
  4. Underwent WMT.

Exclusion criteria

Exclusion Criteria:

  1. Complicated with certain brain disease, including tumor,injury,cerebrovascular disease;
  2. Complicated with other severe disease, including cancers, organ failure, heart diseases;
  3. Stereotypy associated with autism spectrum disorder;
  4. With a confirmed diagnosis of psychiatric diseases, such as bipolar disorders; schizophrenia and major depressive disorders;
  5. obsessive-compulsive disorder at baseline considered to be the primary cause of impairment at baseline;
  6. Medications use affecting gut microbiota such as antibiotics and probiotics three months before WMT.
  7. Other neurologic disorders other than TS that could influence the evaluation of tics.
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

DSM diagnostic criteria

The American Psychiatric Association’s manual of mental health diagnoses. DSM-5 (2013, revised as DSM-5-TR in 2022) replaced DSM-IV, and some studies still name the older edition. “Meets DSM criteria for …” means diagnosed by that edition’s diagnostic criteria, usually by a clinician in an interview.

Clinically significant

Judged by the study doctor to matter for your health or for the study. It is a doctor’s decision, so ask the study team if you are unsure whether something counts.

05

Study design

Phase
Phase 1
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
30 participants (estimated)

Study arms

  • Experimental
    Washed microbiota transplantation

    WMT

    Drug: Washed Microbiota Transplantation

Interventions

  • DrugOrnidazoleStudies of OrnidazoleOrnidazole pageHow we knowJudged by ClinicalTrials.gg, not part of the registry record.

    The prepared microbiota suspension was infused into the participates' lower gut.

    Also known as: Fecal microbiota transplantation

06

What researchers measure

Primary outcomes

  1. The change of Yale Global Tic Severity Scale-Total Tic Score (YGTSS-TTS)

    The YGTSS rating scale is a semistructured clinician- or investigator-administered rating instrument in which participants or caregivers evaluate the number, frequency, intensity, complexity, and interference of motor and phonic tics in the prior week on a 6-point scale from 0 (none) to 5 (severe) \[1\]. The total Motor Tic Severity Score (MTSS; 0-25 points) is added to the total Vocal Tic Severity Score (VTSS; 0-25 points) to determine the TTS (0-50 points).

    Time frame: baseline, 4 weeks, 8 weeks, 12 weeks, 6 months post transplantation

Secondary outcomes

  1. the Clinical Global Impressions-Improvement scale

    Positive treatment response was defined by a score of 1 (very much improved) or 2 (much improved) on the Clinical Global Impressions-Improvement scale. The Clinical Global Impression - Improvement scale is a 7 point scale that requires the clinician to assess how much the patient's illness has improved or worsened relative to a baseline state at the beginning of the intervention. and rated as:1.Very much improved; 2.Much improved; 3. Minimally improved; 4. No change; 5. Minimally worse; 6. Much worse; 7.Very much worse.

    Time frame: 4 weeks, 8 weeks, 12 weeks, 6 months post transplantation

  2. the change of Gilles de la Tourette Syndrome Quality-of-Life Scale score

    The Gilles de la Tourette Syndrome Quality-of-Life Scale with 27 items addresses the issue of how the illness affects patients' well-being. It ranges from 0 to108, and higher values represent a worse outcome.

    Time frame: baseline, 4 weeks, 8 weeks, 12 weeks, 6 months post transplantation

  3. the change of The Swanson, Nolan, and Pelham IV Scale (SNAP-IV)

    It is an 26-item questionnaire that measured three of the ADHD symptoms, inattention, hyperactivity and oppositional defiant disorder. The 26-item checklist is scored on a 4-point Likert scale ranging between Not At All (0) and Very Much (3).

    Time frame: baseline, 4 weeks, 8 weeks, 12 weeks, 6 months post transplantation

  4. change of the Sleep Disturbance Scale for Children (SDSC)

    The SDSC was 26-item test measuring sleep problems and each item received a value from 0 to 4, with higher scores indicating more severe sleep disorders.

    Time frame: baseline, 4 weeks, 8 weeks, 12 weeks, 6 months post transplantation

  5. change of the Gastrointestinal Symptom Rating Scale (GSRS) .

    It is based on 15 questions which are scored into 5 domains: abdominal pain, reflux, indigestion, diarrhea, and constipation. Each item weights from 1 to 7, with higher scores reflecting more severe symptoms.

    Time frame: baseline, 4 weeks, 8 weeks, 12 weeks, 6 months post transplantation

  6. the difference of the gut microbe composition between individuals with TS and healthy children by sequencing faecal metagenome.

    The composition of the gut microbiota is evaluated by sequencing faecal metagenome. We evaluate the differences in the structure of the flora and its metabolism between individuals with TS and control children at the phylum, genus and species levels of the intestinal flora, and to develop a model for predicting the structure of the flora.

    Time frame: baseline, 12 weeks, 6 months post transplantation

07

Study locations

2 of 2 sites recruiting
  • Department of Microbiota Medicine & Medical Centre for Digestive Diseases, The Second Affiliated Hospital of Nanjing Medical University
    Nanjing, Jiangsu 210011, China
    Recruiting
    • Faming Zhang, PhD,MD · Contactfzhang@njmu.edu.cn · 86-025-58509883
    • Faming Zhang, MD,PhD · Principal investigator
  • SIR RUN RUN hospital of Nanjing Medical University
    Nanjing, Jiangsu 210011, China
    Recruiting
08

References and documents

Publications

  • Hoffman BU, Lumpkin EA. A gut feeling. Science. 2018 Sep 21;361(6408):1203-1204. doi: 10.1126/science.aau9973. No abstract available. PubMed 30237346 ↗
  • Foster JA. Targeting the Microbiome for Mental Health: Hype or Hope? Biol Psychiatry. 2017 Oct 1;82(7):456-457. doi: 10.1016/j.biopsych.2017.08.002. No abstract available. PubMed 28870296 ↗
  • Roessner V, Plessen KJ, Rothenberger A, Ludolph AG, Rizzo R, Skov L, Strand G, Stern JS, Termine C, Hoekstra PJ; ESSTS Guidelines Group. European clinical guidelines for Tourette syndrome and other tic disorders. Part II: pharmacological treatment. Eur Child Adolesc Psychiatry. 2011 Apr;20(4):173-96. doi: 10.1007/s00787-011-0163-7. Erratum In: Eur Child Adolesc Psychiatry. 2011 Jul;20(7):377. PubMed 21445724 ↗
  • Peng Z, Xiang J, He Z, Zhang T, Xu L, Cui B, Li P, Huang G, Ji G, Nie Y, Wu K, Fan D, Zhang F. Colonic transendoscopic enteral tubing: A novel way of transplanting fecal microbiota. Endosc Int Open. 2016 Jun;4(6):E610-3. doi: 10.1055/s-0042-105205. Epub 2016 Apr 28. PubMed 27556065 ↗
  • Zhang F, Cui B, He X, Nie Y, Wu K, Fan D; FMT-standardization Study Group. Microbiota transplantation: concept, methodology and strategy for its modernization. Protein Cell. 2018 May;9(5):462-473. doi: 10.1007/s13238-018-0541-8. Epub 2018 Apr 24. PubMed 29691757 ↗
09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Apr 2024 (actual). Primary completion is estimated for Oct 2027, 42 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 30, 2018
First posted
Dec 5, 2018
StartActual
Apr 17, 2024
Primary completionEst.
Oct 31, 2027
CompletionEst.
Oct 31, 2027
Last update
Aug 19, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 19, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03764748
Lead sponsor
The Second Hospital of Nanjing Medical University
Responsible party
Faming Zhang (Professor, Gastroenterology, The Second Hospital of Nanjing Medical University) — Principal investigator
First posted
Dec 5, 2018
Start date
Apr 17, 2024
Primary completion
Oct 31, 2027 (estimated)
Completion
Oct 31, 2027 (estimated)
Last update
Aug 19, 2024

Study contacts

Faming Zhang, MD; PHD
Contact
fzhang@njmu.edu.cn
025-58509883
Faming Zhang, MD; PHD
study chair · The Second Hospital of Nanjing Medical University

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Studies of the drug tested here: Ornidazole

Start the discussion